 FREEHOLD, N.J., May 25, 2022 GLOBE NEWSWIRE -- Avalon GloboCare Corp. NASDAQ: AVCO, a leading global developer of innovative cell-based technologies and therapeutics, announced today that David Jin, M.D., Ph.D., President and Chief Executive Officer, and Luisa Ingargiola, Chief Financial Officer, of Avalon GloboCare, will be presenting at the Jefferies 2022 Healthcare Conference which is being held on June 810, 2022 in New York City. 